Clinical Trial Update: Dietary Methionine Restriction Plus Temozolomide for Recurrent GBM [Phase 1]

View source ↗

Summary

Phase 1 trial of dietary methionine restriction with temozolomide for recurrent glioblastoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Glioblastoma Multiforme | Phase 1 | Status: TERMINATED